CASE REPORT article
Front. Hum. Neurosci.
Sec. Brain Health and Clinical Neuroscience
Volume 19 - 2025 | doi: 10.3389/fnhum.2025.1585730
Anti-LGI1 encephalitis and co-existence of MOG-IgG: a case report and literature review
Provisionally accepted
- Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Anti-leucine-rich glioma-inactivated-1 (LGI1) encephalitis is an autoimmune disorder characterized by antibodies that target LGI1 (LGI1-IgG). It typically presents with cognitive impairment, psychiatric disturbances, and faciobrachial dystonic seizures (FBDS). Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is currently recognized as a demyelinating disease of the central nervous system (CNS) mediated by antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG). The co-occurrence of anti-LGI1 encephalitis and MOG-IgG is a rare phenomenon. Methods: We report a case of anti-LGI1 antibody encephalitis combined with MOG-IgG. A comprehensive literature search was conducted using the PubMed and Embase databases. We utilized the following search terms: ("Limbic Encephalitis"[MeSH Terms] OR ("autoimmune encephalitis"[Title/Abstract] OR "AE"[Title/Abstract])) AND ("Myelin-Oligodendrocyte Glycoprotein"[MeSH Terms] OR "demyelinating autoimmune diseases, cns"[MeSH Terms] OR ("MOG-IgG"[Title/Abstract] OR "MOGAD"[Title/Abstract])). The search was constrained to the period from January 1, 2010, to December 31, 2024. Results: A total of nine papers involving eleven patients were included in the study. Three patients exhibited MOG-IgG in combination with LGI1-IgG. The majority of cases presented with encephalopathic symptoms. Visual changes were observed in a few cases with low titers of serum MOG-IgG or solely in the presence of MOG-IgG in the cerebrospinal fluid (CSF).The occurrence of anti-LGI1 encephalitis alongside MOG-IgG is a relatively rare phenomenon. The clinical manifestation of encephalopathy in patients with coexisting antibodies presents a significant challenge for clinicians regarding timely diagnosis, highlighting the need for increased vigilance in daily practice.
Keywords: myelin oligodendrocyte glycoprotein antibody, Anti-LGI1 antibody, Encephalitis, anti-LGI1 and anti-MOG, co-existing antibodies and autoimmune encephalitis, multiple antibodies and autoimmune encephalitis
Received: 01 Mar 2025; Accepted: 25 Jun 2025.
Copyright: © 2025 Ci, Lin, Wu, Ma and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jie Lu, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.